Cargando…
State-of-the-Art Management of Complications of Myeloma and Its Treatment
Multiple myeloma is an incurable disease, although patient survival has increased with the availability of novel agents. Both multiple myeloma and its therapies often affect the renal, immune, skeletal, hematologic, and nervous systems. The resulting organ dysfunctions often impair the quality of li...
Autores principales: | Hartley-Brown, Monique A., Sullivan, Daniel M., Baz, Rachid |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905716/ https://www.ncbi.nlm.nih.gov/pubmed/20671999 http://dx.doi.org/10.1155/2010/343089 |
Ejemplares similares
-
Antibody-drug conjugate therapies in multiple myeloma—what’s next on the horizon?
por: Hartley-Brown, Monique, et al.
Publicado: (2022) -
Current State of Art Management for Vascular Complications after Liver Transplantation
por: Hejazi Kenari, S. Kamran, et al.
Publicado: (2014) -
Minimal Residual Disease in Multiple Myeloma: State of the Art and Future Perspectives
por: Mina, Roberto, et al.
Publicado: (2020) -
Current State of the Art and Prospects of T Cell-Redirecting Bispecific Antibodies in Multiple Myeloma
por: Hosny, Mashhour, et al.
Publicado: (2021) -
Minimal Residual Disease in Multiple Myeloma: State of the Art and Applications in Clinical Practice
por: Gozzetti, Alessandro, et al.
Publicado: (2020)